Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schwartsmann

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
Malignant melanomaG Schwartsmann, D R Parkinson
European Journal of Cancer & Clinical Oncology|June 1, 1987
Resistance of HL-60 promyelocytic leukemia cells to induction of differentiation and its reversal by combination treatmentG Schwartsmann, H M Pinedo, A Leyva
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapyD B Cornelio, R Roesler, G Schwartsmann
Cancer Treatment Reviews|April 6, 1999
The systemic treatment of AIDS-related Kaposi's sarcomaG Schwartsmann, S Stefani, R U Villarroel
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1988
The main steps in the development of anticancer agentsG Schwartsmann, B Winograd, H M Pinedo
Current Opinion in Oncology|December 1, 1992
Laboratory and phase I studies of new cancer drugsP Workman, S B Kaye, G Schwartsmann
The Lancet. Oncology|March 21, 2002
Malignant disease and von Willebrand factorG Schwartsmann, D C Damin, I Roisemberg
Seminars in Oncology|September 5, 1998
Gemcitabine and paclitaxel combinations in non-small cell lung cancerP Dombernowsky, G Giaccone, A Sandler, et al.
Oral Diseases|February 20, 2007
The egos and the goals of reporting resultsD D Rosa, A C Pasqualotto, G Schwartsmann
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 18, 2005
Sentinel lymph node in carcinoma of the anal canal: a reviewD C Damin, M A Rosito, G Schwartsmann
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
Malignant melanomaG Schwartsmann, D R Parkinson
European Journal of Cancer & Clinical Oncology|June 1, 1987
Resistance of HL-60 promyelocytic leukemia cells to induction of differentiation and its reversal by combination treatmentG Schwartsmann, H M Pinedo, A Leyva
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapyD B Cornelio, R Roesler, G Schwartsmann
Cancer Treatment Reviews|April 6, 1999
The systemic treatment of AIDS-related Kaposi's sarcomaG Schwartsmann, S Stefani, R U Villarroel
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1988
The main steps in the development of anticancer agentsG Schwartsmann, B Winograd, H M Pinedo
Current Opinion in Oncology|December 1, 1992
Laboratory and phase I studies of new cancer drugsP Workman, S B Kaye, G Schwartsmann
The Lancet. Oncology|March 21, 2002
Malignant disease and von Willebrand factorG Schwartsmann, D C Damin, I Roisemberg
Seminars in Oncology|September 5, 1998
Gemcitabine and paclitaxel combinations in non-small cell lung cancerP Dombernowsky, G Giaccone, A Sandler, et al.
Oral Diseases|February 20, 2007
The egos and the goals of reporting resultsD D Rosa, A C Pasqualotto, G Schwartsmann
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 18, 2005
Sentinel lymph node in carcinoma of the anal canal: a reviewD C Damin, M A Rosito, G Schwartsmann
Pageof 9